Y-mAbs Therapeutics downgraded to underperform from neutral at BofA Securities

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody-based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply